ATE478947T1 - Kontinuierliche in vitro-evolution. - Google Patents

Kontinuierliche in vitro-evolution.

Info

Publication number
ATE478947T1
ATE478947T1 AT99918964T AT99918964T ATE478947T1 AT E478947 T1 ATE478947 T1 AT E478947T1 AT 99918964 T AT99918964 T AT 99918964T AT 99918964 T AT99918964 T AT 99918964T AT E478947 T1 ATE478947 T1 AT E478947T1
Authority
AT
Austria
Prior art keywords
mutant
mrna
population
protein
rna
Prior art date
Application number
AT99918964T
Other languages
English (en)
Inventor
Gregory Coia
Peter Hudson
Peter Iliades
Robert Irving
Original Assignee
Diatech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diatech Pty Ltd filed Critical Diatech Pty Ltd
Application granted granted Critical
Publication of ATE478947T1 publication Critical patent/ATE478947T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/127—RNA-directed RNA polymerase (2.7.7.48), i.e. RNA replicase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/082—Hepadnaviridae (F), e.g. hepatitis B virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1041—Ribosome/Polysome display, e.g. SPERT, ARM
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
AT99918964T 1998-05-08 1999-05-07 Kontinuierliche in vitro-evolution. ATE478947T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP3445A AUPP344598A0 (en) 1998-05-08 1998-05-08 Continuous one step in-vitro evolution
PCT/AU1999/000341 WO1999058661A1 (en) 1998-05-08 1999-05-07 Continuous in vitro evolution

Publications (1)

Publication Number Publication Date
ATE478947T1 true ATE478947T1 (de) 2010-09-15

Family

ID=3807699

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99918964T ATE478947T1 (de) 1998-05-08 1999-05-07 Kontinuierliche in vitro-evolution.

Country Status (9)

Country Link
US (1) US6562622B1 (de)
EP (1) EP1075513B8 (de)
JP (2) JP4519318B2 (de)
AT (1) ATE478947T1 (de)
AU (1) AUPP344598A0 (de)
CA (1) CA2328515C (de)
DE (1) DE69942701D1 (de)
ES (1) ES2351275T3 (de)
WO (1) WO1999058661A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030170820A1 (en) * 1998-05-08 2003-09-11 Gregory Coia Continuous in- vitro evolution
US7153655B2 (en) 1998-06-16 2006-12-26 Alligator Bioscience Ab Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequence
AU4854999A (en) * 1998-07-02 2000-01-24 Invitro Diagnostics, Inc. Methods, compositions and apparatus for making nucleic acid molecules having a selected affinity to a target molecule
US20010039014A1 (en) 2000-01-11 2001-11-08 Maxygen, Inc. Integrated systems and methods for diversity generation and screening
DK1268766T3 (da) 2000-03-31 2006-04-10 Cambridge Antibody Tech Forbedringer af ribosom-display
EP1652919A1 (de) * 2000-03-31 2006-05-03 Cambridge Antibody Technology LTD Verbesserungen in Bezug auf Ribosom-Komplexe als Selektionspartikel
US6958213B2 (en) 2000-12-12 2005-10-25 Alligator Bioscience Ab Method for in vitro molecular evolution of protein function
US20030170686A1 (en) * 2001-12-07 2003-09-11 Rene Hoet Method and apparatus for washing magnetically responsive particles
CA2485506C (en) 2002-05-17 2012-02-28 Alligator Bioscience Ab A method for in vitro molecular evolution of protein function
US8557743B2 (en) 2002-09-05 2013-10-15 Dyax Corp. Display library process
CA2503890A1 (en) * 2002-11-01 2004-05-13 Evogenix Pty Ltd Mutagenesis methods using ribavirin and/or rna replicases
KR101250364B1 (ko) 2004-12-13 2013-04-05 세파론 오스트레일리아 (브이아이씨) 피티와이 엘티디 오스테오프로테게린 변이체 단백질
DE102005037349A1 (de) * 2005-08-08 2007-02-15 Geneart Ag Verfahren für die kontinuierliche zielgerichtete Evolution von Proteinen in vivo
US7910695B2 (en) * 2006-06-29 2011-03-22 The Invention Science Fund I, Llc Methods for arbitrary peptide synthesis
US7858342B2 (en) * 2006-06-29 2010-12-28 The Invention Science Fund I, Llc Apparatus for arbitrary peptide synthesis
US7923533B2 (en) * 2006-06-29 2011-04-12 The Invention Science Fund I, Llc Methods for arbitrary peptide synthesis
US7879975B2 (en) * 2006-06-29 2011-02-01 The Invention Science Fund I, Llc Methods for arbitrary peptide synthesis
US7777002B2 (en) * 2006-06-29 2010-08-17 The Invention Science Fund I, Llc Methods for arbitrary peptide synthesis
WO2008114011A2 (en) * 2007-03-19 2008-09-25 Medimmune Limited Fc polypeptide variants obtained by ribosome display methodology
CN101458255B (zh) * 2007-12-14 2013-03-06 武汉大学 丙型肝炎病毒包膜抗原夹心法试剂盒及检测方法
CA2805653A1 (en) 2010-07-20 2012-01-26 Cephalon Australia Pty Ltd Anti-il-23 heterodimer specific antibodies
MX2014003689A (es) 2011-09-30 2014-12-05 Teva Pharmaceuticals Australia Pty Ltd Anticuerpos contra tl1a y sus usos.
PT2951208T (pt) 2013-02-01 2019-12-30 Univ California Anticorpos anti-cd83 e sua utilização
KR102489953B1 (ko) 2013-02-07 2023-01-20 씨에스엘 리미티드 Il-11r 결합 단백질 및 이의 용도
US10870704B2 (en) 2014-10-23 2020-12-22 Kira Biotech Pty Limited CD83 binding proteins and uses thereof
EP3233120A4 (de) 2014-12-19 2018-05-30 Monash University Il-21-antikörper
CN108368167B (zh) 2015-11-27 2023-09-05 杰特有限公司 Cd131结合蛋白及其应用
CA3158174A1 (en) 2019-10-28 2021-05-06 Monash University Antibodies for binding plasmin
JP7807372B2 (ja) 2019-12-20 2026-01-27 ハドソン インスティチュート オブ メディカル リサーチ Ｃｘｃｌ１０結合タンパク質及びその使用
WO2022260718A1 (en) * 2021-06-12 2022-12-15 Lin Shi Lung Novel replicase cycling reaction (rcr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786600A (en) 1984-05-25 1988-11-22 The Trustees Of Columbia University In The City Of New York Autocatalytic replication of recombinant RNA
ES2118066T3 (es) * 1989-10-05 1998-09-16 Optein Inc Sintesis y aislamiento, exentos de celulas, de nuevos genes y polipeptidos.
AU4930993A (en) 1992-09-24 1994-04-12 Public Health Research Institute Of The City Of New York, Inc., The Coupled replication-translation methods and kits for protein synthesis

Also Published As

Publication number Publication date
EP1075513A4 (de) 2003-07-16
DE69942701D1 (de) 2010-10-07
JP2002515224A (ja) 2002-05-28
US6562622B1 (en) 2003-05-13
EP1075513A1 (de) 2001-02-14
CA2328515C (en) 2011-10-18
AUPP344598A0 (en) 1998-06-04
CA2328515A1 (en) 1999-11-18
JP2010119396A (ja) 2010-06-03
WO1999058661A1 (en) 1999-11-18
ES2351275T3 (es) 2011-02-02
EP1075513B1 (de) 2010-08-25
JP4519318B2 (ja) 2010-08-04
EP1075513B8 (de) 2010-09-29

Similar Documents

Publication Publication Date Title
DE69942701D1 (de) Kontinuierliche in vitro-evolution.
Lukauskas et al. Decoding chromatin states by proteomic profiling of nucleosome readers
US20220260581A1 (en) Peptide constructs and assay systems
He et al. Facile synthesis of site-specifically acetylated and methylated histone proteins: reagents for evaluation of the histone code hypothesis
Kraus PARPs and ADP-ribosylation: 50 years… and counting
Müller et al. In Vitro Biosynthesis of the Prepeptide of Type‐III Lantibiotic Labyrinthopeptin A2 Including Formation of a C C Bond as a Post‐Translational Modification
Grosjean Modification and editing of RNA: historical overview and important facts to remember
Elschenbroich et al. Isolation of cell surface proteins for mass spectrometry-based proteomics
Mears et al. A structural model for the large subunit of the mammalian mitochondrial ribosome
CY1115634T1 (el) Μεσα ανταγωνιστικης επιλεκτικης συνδεσης της πρωτεϊνης συνδεσης οστεοπροτεγερινης
Koeris et al. Modulation of ADAR1 editing activity by Z-RNA in vitro
Lee et al. Structural and functional insight into an unexpectedly selective N-methyltransferase involved in plantazolicin biosynthesis
ATE470712T1 (de) Nukleinsäureliganden mit hoher affinität zu dem c5-protein des komplementsystems
MY148907A (en) Method for linking sequences of interest
NO930011L (no) Tilfeldig boi-oligomer bibilotek og fremgangsmaate for syntese og anvendelse derav
van der Heden van Noort et al. Synthesis of mono-ADP-ribosylated oligopeptides using ribosylated amino acid building blocks
Kojima et al. PCR amplification of 4′-thioDNA using 2′-deoxy-4′-thionucleoside 5′-triphosphates
Barrick et al. Selection of RNA-binding peptides using mRNA-peptide fusions
Mitchener et al. Janus bioparticles: asymmetric nucleosomes and their preparation using chemical biology approaches
ATE337396T1 (de) Kombinatorische bibliotheken heteromerer cytotoxischer proteine
Amikura et al. Multiple amino acid-excluded genetic codes for protein engineering using multiple sets of tRNA variants
Kolpashchikov et al. Synthesis of base-substituted dUTP analogues carrying a photoreactive group and their application to study human replication protein A
Peplow A conversation with Ting Zhu
Matsuo et al. Efficient synthesis of 13C, 15N-labeled RNA containing the cap structure m7GpppA
WO2003062417A1 (fr) Produit de ligation arn-adn, et utilisation correspondante

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties